A detailed history of Bessemer Group Inc transactions in Twist Bioscience Corp stock. As of the latest transaction made, Bessemer Group Inc holds 140 shares of TWST stock, worth $6,736. This represents 0.0% of its overall portfolio holdings.

Number of Shares
140
Holding current value
$6,736
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$36.72 - $58.88 $5,140 - $8,243
140 New
140 $6,000
Q2 2023

Aug 10, 2023

BUY
$11.49 - $20.46 $5,986 - $10,659
521 New
521 $11,000
Q3 2020

Nov 12, 2020

SELL
$45.46 - $78.79 $2.13 Million - $3.69 Million
-46,800 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$26.4 - $45.3 $678,480 - $1.16 Million
25,700 Added 121.8%
46,800 $2.12 Million
Q1 2020

Apr 30, 2020

BUY
$19.71 - $35.15 $415,881 - $741,665
21,100 New
21,100 $645,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.71B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.